Loading…
Cryoport, Inc. is projected to rise to $21.71 by 2027, a +34% move from its current price of $16.17. CYRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $15.82 | $16.18 | $16.54 | +0.04% |
| Jul 14 | $15.68 | $16.18 | $16.71 | +0.08% |
| Jul 15 | $15.57 | $16.19 | $16.83 | +0.12% |
| Jul 16 | $15.49 | $16.20 | $16.94 | +0.17% |
| Jul 17 | $15.41 | $16.20 | $17.04 | +0.21% |
| Jul 18 | $15.34 | $16.21 | $17.13 | +0.25% |
| Jul 19 | $15.28 | $16.22 | $17.21 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.28 | $16.22 | $17.21 | +0.29% |
| Week 2 | $14.95 | $16.26 | $17.69 | +0.58% |
| Week 3 | $14.72 | $16.31 | $18.08 | +0.87% |
| Week 4 | $14.53 | $16.36 | $18.42 | +1.17% |
| Week 5 | $14.37 | $16.41 | $18.74 | +1.46% |
| Week 6 | $14.23 | $16.45 | $19.03 | +1.76% |
| Week 7 | $14.10 | $16.50 | $19.31 | +2.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry.
Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release.
In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Cryoport, Inc. (CYRX) is currently trading at $16.17, with a market cap of $815.01M. It ranks 2687 by market capitalization.
A major floor 52.3% below — a decisive break under it would weaken the trend.
The nearest floor, 11.1% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 10.1% above — clearing it would confirm fresh momentum.
Key CYRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CYRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.49 | Buy | $15.70 | Buy |
| MA 10 | $15.68 | Buy | $15.58 | Buy |
| MA 20 | $15.29 | Buy | $15.36 | Buy |
| MA 50 | $14.33 | Buy | $14.20 | Buy |
| MA 100 | $11.59 | Buy | $12.66 | Buy |
| MA 200 | $10.58 | Buy | $11.14 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.40 | Neutral |
| Stoch RSI (14) | 65.35 | Neutral |
| CCI (20) | 117.18 | Buy |
| Williams %R (14) | -7.24 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | 9.55 | Buy |
| Bollinger %B (20,2) | 0.89 | Neutral |
| Stochastic %K (14) | 92.76 | Sell |
| TRIX (15) | 0.41 | Buy |
| Awesome (5,34) | 0.24 | Buy |
| Ultimate (7,14,28) | 60.62 | Neutral |
| Momentum (10) | 0.29 | Buy |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 15.54 | Buy |
| ADX (14) | 22.31 | Buy |
| ATR (14) | 0.32 | Info |
The 30-day technical picture is bullish. RSI14 is 60 and the moving averages point higher, with SMA50 at $14.33 and SMA200 at $10.58. The 30-day range runs from $13.95 to $18.75, reflecting a near-term trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.72 | $16.17 | $22.55 | 0% | Neutral | |
| $17.57 | $21.71 | $28.19 | +34% | Bullish | |
| $22.48 | $28.41 | $38.07 | +76% | Bullish | |
| $27.93 | $35.96 | $49.39 | +122% | Bullish | |
| $34.02 | $44.52 | $62.42 | +175% | Bullish | |
| $38.91 | $51.68 | $73.78 | +220% | Bullish | |
| $40.05 | $53.94 | $78.27 | +234% | Bullish | |
| $46.53 | $63.46 | $93.46 | +292% | Bullish | |
| $52.56 | $72.56 | $108.34 | +349% | Bullish | |
| $57.72 | $80.62 | $121.91 | +399% | Bullish | |
| $92.99 | $136.84 | $218.31 | +746% | Bullish | |
| $221.47 | $355.86 | $614.23 | +21.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $7.72 | $16.17 | $19.33 | +0.00% |
| August 2026 | $13.84 | $16.25 | $19.55 | +0.51% |
| September 2026 | $14.21 | $16.79 | $20.38 | +3.32% |
| October 2026 | $14.93 | $17.73 | $21.69 | +5.58% |
| November 2026 | $15.14 | $18.05 | $22.22 | +1.79% |
| December 2026 | $15.21 | $18.20 | $22.55 | +0.86% |
Click any year to see its month-by-month CYRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CYRX is projected to trade between $7.72 and $22.55, averaging $16.17 — a potential gain of 0% from today's $16.17. A consolidation phase looks the most probable path here.
Cryoport, Inc.'s 2027 outlook centres on $21.71, within a $17.57 to $28.19 range. That is up +34% on the projected 2026 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2028, CYRX could reach as high as $38.07, with a base case around $28.41 and support toward $22.48 — roughly +76% from $16.17. Buyers look set to stay in control over this stretch.
Expect CYRX to range from $27.93 to $49.39 through 2029. The $35.96 average target implies a +122% move from current prices. That is up +27% on the projected 2028 average. Momentum favours further upside here.
The CYRX price prediction for 2030 points to an average of $44.52 (low $34.02, high $62.42) — a potential gain of +175% on today's $16.17. Buyers look set to stay in control over this stretch.
In 2031, CYRX is projected to trade between $38.91 and $73.78, averaging $51.68 — a potential gain of +220% from today's $16.17. That is up +16% on the projected 2030 average. Momentum favours further upside here.
Cryoport, Inc.'s 2032 outlook centres on $53.94, within a $40.05 to $78.27 range. That is up +4% on the projected 2031 average. That marks a +234% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CYRX could reach as high as $93.46, with a base case around $63.46 and support toward $46.53 — roughly +292% from $16.17. Momentum favours further upside here.
Expect CYRX to range from $52.56 to $108.34 through 2034. The $72.56 average target implies a +349% move from current prices. That is up +14% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CYRX price prediction for 2035 points to an average of $80.62 (low $57.72, high $121.91) — a potential gain of +399% on today's $16.17. Momentum favours further upside here.
In 2040, CYRX is projected to trade between $92.99 and $218.31, averaging $136.84 — a potential gain of +746% from today's $16.17. That is up +70% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Cryoport, Inc.'s 2050 outlook centres on $355.86, within a $221.47 to $614.23 range. That is up +160% on the projected 2040 average. That marks a +21.0x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CYRX today (≈ 61.842919 CYRX) could be worth
$22,007.51
+$21,007.51 (+2101%) by 2050 · US Dollar
Based on the average projected CYRX price of $355.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CYRXwould be worth at today's price.
$1,000 invested in CYRX on Jul 10, 2025 (≈ 133.155788 CYRX) would be worth
$2,153.13
+$1,153.13 (+115.3%) today · 2.15× · US Dollar
Based on a CYRX entry price of $7.51 vs. today's $16.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.49 | $1,043.9 | +4.4% |
| 1 month ago | $14.77 | $1,094.79 | +9.5% |
| 3 months ago | $9.67 | $1,672.18 | +67.2% |
| 6 months ago | $10.65 | $1,518.31 | +51.8% |
| 1 year ago | $7.51 | $2,153.13 | +115.3% |
| All time (5.0y) ago | $58.52 | $276.32 | -72.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CYRX forecast.
Our base-case forecast reaches $32.00 around 2029.
Implied market cap at $32.00: $1.61B
The multi-year forecast shows an upside trajectory. The 2026 average is $16.17 (min $7.72, max $22.57) with a 0% ROI and neutral sentiment. In 2027 the average rises to $21.73 (min $17.58, max $28.22) with a 34.4% ROI and bullish sentiment.
The path continues higher: 2028 avg $28.40 (min $22.47, max $38.06) with 75.7% ROI, 2029 avg $36.01 (min $27.97, max $49.45) with 122.7% ROI, and 2030 avg $44.56 (min $34.05, max $62.48) with 175.6% ROI. The bullish trajectory extends through 2031–2035, with 2031 avg $51.65 (ROI 219.4%), 2032 avg $53.97 (ROI 233.8%), 2033 avg $63.53 (ROI 292.9%), 2034 avg $72.54 (ROI 348.6%), and 2035 avg $80.65 (ROI 398.8%). By 2040 the forecast shows an average of $136.77 (min $92.94, max $218.19) and a 745.8% ROI, and by 2050 an average of $356.14 (min $221.64, max $614.73) with a 2102.5% ROI.
These projections imply substantial upside risk and upside potential over the long term, though they are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $34.05, an average of $44.56, and a max of $62.48, with a 175.6% ROI and bullish sentiment.
Near term, the 2026 forecast has an average of $16.17 with a 0% ROI and neutral sentiment. From 2027 onward, the forecast shows rising averages (e.g., 2027 avg $21.73, ROI 34.4%, bullish) indicating upside potential over the longer term.
Yes. The forecast indicates a path where higher-year max values exceed $100, including 2035 max of $121.97 (min $57.74, avg $80.65, ROI 398.8%, bullish). Additional years show even higher max prices, such as 2040 max $218.19 and 2050 max $614.73.
The 2050 max forecast is $614.73, with an average of $356.14 and a min of $221.64, corresponding to a 2102.5% ROI and bullish sentiment.
The 30-day range is $13.95 to $18.75, with support at $14.38 and resistance at $16.50. RSI14 is 60, SMA50 is $14.33, SMA200 is $10.58, and the 30-day volatility is 40% with bullish short-term sentiment.
Cryoport, Inc. Community Discussion
0Share your Cryoport, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.